Cjc-1295

Overview

CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary to secrete growth hormone. Its appeal is a sustained, longer-lasting GH release, which makes it popular for anti-aging, muscle growth, fat loss, and recovery. As a peptide it requires reconstitution and subcutaneous injection, with purity and storage mattering.

The Bottom Line

CJC-1295 sits on firmer ground than many peptides, with a near-top research grade and a handful of human studies confirming it raises GH and IGF-I. The honest caveat is scale: the literature is small (only 9 studies), much of the real-world use is self-directed and off-label, and benefits to body composition are gradual rather than dramatic.

Evidence Quality

The A− grade is weighted across just 9 peer-reviewed studies (3 RCTs, 3 animal, 3 reviews), with 6 supporting and 3 mixed findings and no refuting results. The direction is positive, but the evidence base is thin compared with better-studied compounds.

What the Research Shows

Observational human work shows CJC-1295 produces prolonged increases in growth hormone and IGF-I in healthy adults. Animal studies found once-daily dosing normalized growth and body composition in GHRH-knockout mice, and identified CJC-1295 as a stable GHRH analog with an extended plasma half-life. Another human study showed GH secretion rose while pulsatility was preserved, suggesting clinical potential. A netnography of female users documented self-medication for weight loss, muscle gain, more youthful skin, better sleep, and injury healing, useful as a picture of real-world use but not as controlled evidence.

Community Sentiment

CJC-1295 has a large community footprint: across 444 reports, sentiment ran 38% positive, 36% neutral, and 26% negative, with mentions up dramatically over time. The most-cited effects were improved sleep, fat loss, muscle, and recovery. The most-cited side effects were notable, flushing, sleep disruption, throat tightness, and allergic reaction, which deserve attention given how often allergic-type reactions appear.

Dosage

A standard approach is 1-2 mg per week divided into 2-3 injections, frequently given before bed to align with the natural nighttime GH pulse, and typically administered subcutaneously.

Effectiveness and Availability

Users report the best results when CJC-1295 is stacked with a GHRP such as GHRP-2 or GHRP-6, with body-composition changes generally taking 2-3 months to show and outcomes varying by age and baseline GH. It is sold as a research chemical for research purposes only and is not FDA-approved, so sourcing from reputable vendors and watching for quality variation matters.